Need a Good Medicare Advantage Plan? They're Tough to Find for Poorer Americans
By Dennis Thompson HealthDay Reporter
THURSDAY, July 25, 2024 -- Medicare Advantage plans are touted as a great alternative to traditional Medicare, offering seniors easier access to doctors, hospitals and prescription drugs.
But access to a good Medicare Advantage plan relies heavily on where a person lives, a new study finds.
People are less likely to find a five-star Medicare Advantage plan if they live in a U.S. county with higher poverty and unemployment, researchers reported in the journal JAMA Network Open.
These geographic disparities could be keeping federal funds from reaching people most in need, researchers said.
“What this means is that Medicare beneficiaries living in counties with greater social disadvantage have fewer opportunities to choose highly rated Medicare Advantage plans that could be delivering high-quality care,” said lead researcher Avni Gupta, a recent doctoral graduate of health policy and management from the New York University School of Global Public Health.
More than half of all Medicare beneficiaries are enrolled in Medicare Advantage plans, amounting to nearly 31 million people, researchers said in background notes.
To help consumers compare the plans, the U.S. Centers for Medicare & Medicaid Services provide a five-star rating system that calculates scores based on nearly 40 indicators, researchers said.
“Star ratings are meant to capture the performance of Medicare Advantage plans in past years, with better ratings demonstrating higher quality care in areas such as chronic care management, screenings, vaccinations and other preventive services, timely appointments, care coordination, customer service and handling appeals,” Gupta explained in a university news release.
The ratings also determine bonuses and rebate payments that insurance companies receive from CMS. Larger payments to higher-rated plans can translate into better benefits for seniors, researchers said.
For the study, researchers mapped the availability of Medicare Advantage plans in 3,075 counties.
They compared the plans against each county’s poverty, unemployment, education, disability, housing, transportation access and racial/ethnic makeup.
They found that Medicare Advantage plans in the most disadvantaged counties were less likely to have 4.5 stars or higher, and more likely to have ratings of 3.5 stars or lower.
“Our findings imply that beneficiaries who might gain the most from supplemental benefits may only be able to choose from plans that are least likely to have the financial resources to provide these benefits, given that lower star ratings translate to lower bonuses and rebates to insurance plans,” Gupta said.
“Such a pattern of star ratings and county-level social vulnerability could exacerbate inequities in health care access, experience and outcomes,” Gupta continued.
New Medicare policies that account for an area’s vulnerability in the star rating system could help counter these inequities, researchers said. CMS could also consider incentivizing plans to serve such areas.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-26 03:15
Read more
- Texas AG Sues Dallas Doctor Over Transgender Care for Minors
- No Objective Improvement Seen in Cognitive Function With Exercise During Chemo
- Racial, Gender, Socioeconomic Disparities Seen in Teen Alcohol, Drug Screening
- 1998 to 2023 Saw Decline in Triplet, Higher-Order Birth Rate
- Weight-Loss Surgery for Teens Brings Lasting Benefit
- Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of Selarsdi (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara (ustekinumab)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions